期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HER-2／neu·siRNA表达载体的构建及对人乳腺癌细胞株的影响

Vector construction and silencing effects of siRNA to HER-2/neu gene of human breast cancer cell line SK-BR-3
下载PDF
导出
摘要 目的：探讨siRNA对人乳腺癌细胞株SK—BR-3的HER-2／neu基因表达的影响。方法：以HER-2／neu mRNA序列为模板设计合成2对siRNA序列，构建pGenesil-1-HER-2／neusiRNA重组质粒，转化感受态的大肠杆菌，质粒酶切、测序鉴定。转染SK—BR-3细胞48h后，提取RNA进行RT—PCR，采用方差分析（ANOVA），分析RNA干扰效应。结果：成功构建了pGenesil-1-HER-2／neu siRNA重组质粒，成功转染SK—BR-3细胞。重组质粒抑制HER-2／neu基因的表达接近54．45％（P=0．000）。结论：HER-2／neu siRNA重组质粒明显下调HER-2／neu基因在乳腺癌细胞中的表达。 Objective：To investigate the effects of siRNA to HER-2/neu gene of human breast cancer cell line SK-BR-3. Methods： Two pairs of siRNA were designed and synthesized according to the sequence of HER-2/neu mRNA. pGenesil-1-HER-2/neu siRNA recombinant plasmid was then constructed and used to transfected E coll. The constructed plasmids were confirmed by restriction cutting and DNA sequencing. SK-BR-3 cell line was then transfected, and at 48 h later, extracted for total RNA to be detected for expression of HER-2/neu mRNA by RT-PCR. The results was analyzed for gene-silencing effects using ANOVA. Results： pGenesil-l-HER-2/neu siRNA was constructed and SK-BR-3 transfected successfully. RT-PCR analyses found that nearly 54.45% of HER-2/neu mRNA expression in SK-BR-3 was suppressed （ P = 0. 000 ）. Conclusions ： pGenesil-1-HER-2/neu siRNA may significantly inhibit HER-2/neu gene expression in SK-BR-3.
作者 万光霞 林辉 刘浔阳
机构地区 湘潭市中心医院普外二科 中南大学湘雅三医院
出处 《广州医学院学报》 2010年第1期6-9,共4页 Academic Journal of Guangzhou Medical College
关键词 乳腺癌 SK—BR-3 HER-2/NEU SIRNA Breast cancer SK-BR-3 HER-2/neu siRNA
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1谢晓斌,刘启才,张雅洁.抑制人血管内皮生长因子C表达的shRNA逆转录病毒表达载体的构建[J].广州医学院学报,2007,35(2):58-61. 被引量：5
  • 2Jahanzeb M. Adjuvant trastuzumab therapy for HER2- positive breast cancer [ J]. Clin Breast Cancer, 2008, 8 (4) :324-333.
  • 3Kammori M, Kurabayashi R, Kashio M, et al. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer[J]. Oncol Rep, 2008,19 ( 3 ) :651-656.
  • 4Tiezzi DG, Andrade JM, Ribeiro-Silva A,et al. HER-2, p53, to21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjnvant docetaxel plus epirubicin combination[J].BMC Cancer, 2007,26 (7) :36.
  • 5Li X, Lu Y, Liang K, et al. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells [ J ]. Breast Cancer Res, 2005,7 ( 5 ) : R589-597.
  • 6Rastelli F, Crispino S. Factors predictive of response to hormone therapy in breast cancer [ J ]. Tumori, 2008,94 (3) :370-383.
  • 7Menard S, Casalini P, Campiglio M, et al. Role of HER2/ neu in tumor progression and therapy [J].Cell Mol Life Sci, 2004,61 (23) :2965-2978.
  • 8Zhang D, Pal A, Bornmann WG, et al. Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells [ J]. Mol Cancer Ther, 2008,7 (7) : 1846-1850.

二级参考文献10

  • 1Rubbia-Brandt L,Terris B,Giostra E,et al.Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors[J].Clin Cancer Res,2004,10(20):6919-6928.
  • 2Li YS,Kaneko M,Amatya VJ,et al.Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast[J].Pathol Int,2006,56(5):256-261.
  • 3Okada K,Osaki M,Araki K,et al.Expression of hypoxia-inducible factor (HIF-1alpha),VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas[J].Anticancer Res,2005,25(4):3003-3009.
  • 4Wong SY,Herbert Haack,Denise Crowley,et al.Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis,but lymphangiogenesis is unnecessary for lymph node metastasis[J].Cancer Res,2005,65(21):9789-9798.
  • 5Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans[J].Nature,1998,391 (6669):806-811.
  • 6Elbashir SM,Lendeckel W,Tuschl T.RNA interference is mediated by 21-and 22-nucleotide RNAs[J].Genes Dev,2001,15 (2):188-200.
  • 7Miyagishi M,Taira K.RNAi expression vectors in mammalian cells[J].Methods Mol Biol,2004,252:483-491.
  • 8Hannon GJ,Conklin DS.RNA interference by short hairpin RNAs expressed in vertebrate cells[J].Methods Mol Biol,2004,257:255-266.
  • 9Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553.
  • 10Miyazaki H,Patel V,Wang H,et al.Down-regulation of CXCL5 inhibits squamous carcinogenesis[J].Cancer Res,2006,66(8):4279-4284.

共引文献4

广州医学院学报
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部